CJC-1295: With and Without DAC - Research Comparison

CJC-1295: With and Without DAC - Research Comparison

CJC-1295 is a synthetic growth hormone-releasing hormone (GHRH) analog primarily used in research settings to investigate growth hormone secretion and related physiological processes. It exists in two main forms: CJC-1295 without Drug Affinity Complex (DAC), often referred to as Modified GRF 1-29 or Sermorelin, and CJC-1295 with DAC. The presence or absence of the DAC moiety significantly impacts the pharmacokinetic profile and, consequently, the research applications and considerations for quality assessment.

Molecular Structure and Mechanism of Action

Both CJC-1295 forms are based on the first 29 amino acids of the naturally occurring GHRH. This fragment is responsible for binding to the GHRH receptor in the pituitary gland, stimulating the release of growth hormone (GH). The key difference lies in the addition of DAC to CJC-1295, which is a Lysine molecule bound to maleimidopropionic acid (MPA). This modification allows for albumin binding in the bloodstream, extending the half-life.

CJC-1295 without DAC (Modified GRF 1-29/Sermorelin)

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-NH2

Molecular Formula: C₁₂₉H₂₁₉N₃₉O₄₂

Molecular Weight: 3368.96 g/mol

CJC-1295 without DAC acts as a short-acting GHRH analog. It binds to GHRH receptors on somatotrophs in the anterior pituitary, initiating a signaling cascade that leads to the synthesis and release of GH. The pulsatile release of GH following administration mimics the natural physiological pattern.

CJC-1295 with DAC

Sequence: Tyr-D-Ala-Asp-Ala-Ile-Phe-Thr-Gln-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Leu-Ser-Arg-Lys(Maleimidopropionyl)-NH2

Molecular Formula: C₁₅₂H₂₅₂N₄₄O₄₂

Molecular Weight: 3649.4 g/mol (approximately, depending on the specific DAC modification)

The DAC moiety in CJC-1295 extends the half-life significantly. After injection, the DAC forms a covalent bond with albumin in the blood. This albumin-bound complex protects the peptide from degradation and clearance, resulting in a prolonged duration of action. This sustained release pattern leads to a more stable and elevated level of GH compared to CJC-1295 without DAC.

Research Applications

Both forms of CJC-1295 have been investigated in various research settings, primarily focusing on their effects on GH secretion and downstream physiological processes. However, their distinct pharmacokinetic profiles dictate the types of studies for which they are best suited.

CJC-1295 without DAC (Modified GRF 1-29/Sermorelin)

• Pulsatile GH Release Studies: Due to its short half-life, it is ideal for studies examining the acute effects of GHRH stimulation on GH secretion patterns. Researchers can precisely control the timing and magnitude of GH pulses.
• Dose-Response Studies: The rapid clearance allows for accurate assessment of dose-dependent effects on GH release without the confounding factor of prolonged drug exposure.
• Combination Therapies: Its short duration makes it suitable for combining with other GH-modulating agents to study synergistic or antagonistic effects.
• Mechanism of Action Studies: Researchers can use it to investigate the signaling pathways involved in GHRH-mediated GH release.

CJC-1295 with DAC

• Long-Term GH Stimulation Studies: The extended half-life allows for sustained elevation of GH levels over days or weeks, enabling the investigation of chronic GH-dependent effects.
• Metabolic Studies: Researchers can study the impact of sustained GH elevation on metabolic parameters such as insulin sensitivity, lipid metabolism, and body composition.
• Growth and Development Studies: The prolonged GH stimulation can be used to investigate the effects on growth, bone density, and muscle mass.
• Aging-Related Studies: Researchers can explore the potential benefits of sustained GH elevation in mitigating age-related decline in physiological function.

Quality Markers to Look For

Ensuring the quality of CJC-1295, both with and without DAC, is crucial for obtaining reliable and reproducible research results. Several key quality markers should be assessed when sourcing these peptides.

Purity

Definition: The percentage of the peptide in the sample that is the desired sequence, free from other peptides, amino acids, or organic impurities.

Acceptable Range: Ideally, the purity should be ?98% for research purposes. Lower purity may compromise the accuracy of the study and introduce confounding variables.

Analytical Methods:

• High-Performance Liquid Chromatography (HPLC): Reversed-phase HPLC with UV detection is the most common method for determining peptide purity. The area under the peak corresponding to the desired peptide is compared to the total area of all peaks in the chromatogram.
• Mass Spectrometry (MS): Confirms the molecular weight of the peptide and can detect the presence of impurities with different molecular weights. Ideally, HPLC should be coupled with MS (LC-MS) for comprehensive purity assessment.

Practical Tip: Request HPLC and MS data from the supplier before purchasing. Examine the chromatograms for the presence of significant impurity peaks. Ensure the reported molecular weight matches the theoretical molecular weight of the peptide.

Peptide Content

Definition: The actual amount of peptide present in the sample, taking into account factors like water content, residual solvents, and counterions.

Acceptable Range: Ideally, the peptide content should be clearly stated by the supplier, typically expressed as a percentage (e.g., 80% peptide content). A higher peptide content indicates less non-peptide material in the sample.

Analytical Methods:

• Amino Acid Analysis (AAA): Determines the molar ratio of amino acids in the peptide. Deviations from the expected ratios can indicate peptide degradation or the presence of incorrect sequences.
• Quantitative NMR (qNMR): Can be used to quantify the amount of peptide in the sample by comparing the signal intensity of specific protons to an internal standard.

Practical Tip: Don't rely solely on purity. A peptide with 99% purity might still have a low peptide content due to high water content or counterion contamination. Inquire about the peptide content and the methods used for its determination.

Water Content

Definition: The amount of water absorbed by the peptide during synthesis, purification, and storage.

Acceptable Range: Ideally, water content should be ? 10%. Excessive water can contribute to peptide degradation and affect the accuracy of dosing.

Analytical Methods:

• Karl Fischer Titration: A widely used method for determining water content in peptides and other materials.

Practical Tip: Request water content analysis from the supplier. Store peptides under anhydrous conditions to minimize water absorption.

Counterions

Definition: Ions (e.g., acetate, trifluoroacetate (TFA)) that are associated with the peptide to neutralize its charge. TFA is a common counterion used in peptide synthesis and purification.

Acceptable Range: The type and amount of counterion should be specified by the supplier. High levels of TFA can be undesirable due to potential toxicity and interference with biological assays.

Analytical Methods:

• Ion Chromatography: Can be used to quantify the amount of specific counterions in the peptide sample.

Practical Tip: Inquire about the counterion used and its concentration. Consider requesting a peptide with acetate as the counterion, as it is generally considered less toxic than TFA. If TFA is present, ensure its concentration is within acceptable limits for your research application.

Endotoxin Levels

Definition: Lipopolysaccharides (LPS) derived from the outer membrane of Gram-negative bacteria. Endotoxins can contaminate peptide samples during synthesis or handling.

Acceptable Range: Endotoxin levels should be as low as possible, especially for in vivo studies. Typically, levels should be <10 EU/mg (Endotoxin Units per milligram) of peptide.

Analytical Methods:

• Limulus Amebocyte Lysate (LAL) Assay: A sensitive assay for detecting and quantifying endotoxins.

Practical Tip: Request endotoxin testing from the supplier, especially if the peptide will be used in cell culture or animal studies. Use sterile techniques when handling peptides to minimize the risk of endotoxin contamination.

Common Impurities

Peptide synthesis is a complex process, and several impurities can be introduced during the synthesis, purification, and storage of CJC-1295. Understanding these impurities is crucial for assessing the quality of the peptide and interpreting research results.

• Deletion Sequences: Peptides missing one or more amino acids. These arise from incomplete coupling during solid-phase peptide synthesis.
• Truncated Sequences: Peptides that are shorter than the desired sequence due to premature termination of the synthesis.
• Modified Amino Acids: Peptides containing amino acids with incorrect protecting groups or side-chain modifications.
• Diastereomers: Peptides with incorrect stereochemistry at one or more chiral centers.
• Aggregates: Peptides that have self-associated to form larger complexes.
• Solvents and Reagents: Residual solvents (e.g., dimethylformamide (DMF), acetonitrile) and reagents used in the synthesis and purification process.

Practical Tip: Select suppliers that employ robust purification protocols, such as preparative HPLC, to minimize the presence of impurities. Review the HPLC chromatograms carefully for the presence of impurity peaks.

Storage Requirements

Proper storage is essential for maintaining the integrity and stability of CJC-1295. Following these guidelines will help minimize degradation and ensure the peptide remains suitable for research applications.

• Temperature: Store lyophilized (freeze-dried) peptides at -20°C or -80°C. Avoid repeated freeze-thaw cycles, as this can lead to peptide degradation.
• Desiccation: Store peptides under anhydrous conditions in a tightly sealed container with a desiccant (e.g., silica gel). This minimizes water absorption.
• Light Exposure: Protect peptides from light, as some amino acids are light-sensitive. Store peptides in amber vials or wrap vials in foil.
• Solution Storage: If the peptide is reconstituted in solution, store it at -20°C in single-use aliquots. The stability of the peptide in solution depends on the solvent, pH, and concentration. Generally, acidic solutions (pH 3-6) are more stable than neutral or basic solutions.
• Shelf Life: Lyophilized peptides, when stored properly, can typically be stored for 1-2 years. Peptides in solution have a shorter shelf life, typically weeks to months, depending on the storage conditions.

Practical Tip: Aliquot the peptide into small portions after reconstitution to avoid repeated freeze-thaw cycles. Date each aliquot to keep track of its age. Monitor the peptide for signs of degradation, such as discoloration or precipitation.

CJC-1295 With and Without DAC: A Comparison Table

Key Takeaways

• CJC-1295 exists in two main forms: with and without DAC, each possessing distinct pharmacokinetic properties and research applications.
• CJC-1295 without DAC (Modified GRF 1-29) has a short half-life and produces pulsatile GH release, suitable for studies requiring precise control over GH stimulation.
• CJC-1295 with DAC has an extended half-life and provides sustained GH elevation, ideal for long-term studies on metabolic and developmental processes.
• Purity, peptide content, water content, counterions, and endotoxin levels are critical quality markers to assess when sourcing CJC-1295.
• Common impurities include deletion sequences, truncated sequences, modified amino acids, and residual solvents.
• Proper storage at low temperatures, under anhydrous conditions, and protected from light is essential for maintaining peptide stability.
• Always request and carefully review the Certificate of Analysis (CoA) from the supplier before purchasing CJC-1295.